Cargando…

β-Arrestin1 promotes the progression of chronic myeloid leukaemia by regulating BCR/ABL H4 acetylation

BACKGROUND: β-Arrestins are scaffold proteins that interact with various cellular signals. Although β-arrestin2 mediates the initiation and progression of myeloid leukaemia, the critical role of β-arrestin1 in the chronic myeloid leukaemia (CML) is still unknown. The aim of this study is to investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qin, R, Li, K, Qi, X, Zhou, X, Wang, L, Zhang, P, Zou, L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2014
Materias:	Molecular Diagnostics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4119990/ https://www.ncbi.nlm.nih.gov/pubmed/24937675 http://dx.doi.org/10.1038/bjc.2014.335

Ejemplares similares

Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia
por: Tan, Li, et al.
Publicado: (2018)

Consensus on BCR‐ABL1 reporting in chronic myeloid leukaemia in the UK
por: Cross, Nicholas C. P., et al.
Publicado: (2018)

Circulating cytokines and small molecules follow distinct expression patterns in acute myeloid leukaemia
por: Islam, Mirazul, et al.
Publicado: (2017)

The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia
por: Hubeek, I, et al.
Publicado: (2005)

Dual transcripts of BCR-ABL & different polymorphisms in chronic myeloid leukaemia patients
por: Nandagopalan, S. Rajashree, et al.
Publicado: (2016)

The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR–ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents
por: Liu, W M, et al.
Publicado: (2002)

T lymphoblastic lymphoma with BCR-ABL negative chronic myeloid leukaemia: a novel association
por: Faizan, Mahwish, et al.
Publicado: (2021)

MicroRNA-100/99a, deregulated in acute lymphoblastic leukaemia, suppress proliferation and promote apoptosis by regulating the FKBP51 and IGF1R/mTOR signalling pathways
por: Li, X-J, et al.
Publicado: (2013)

High TOP2B/TOP2A expression ratio at diagnosis correlates with favourable outcome for standard chemotherapy in acute myeloid leukaemia
por: Song, J H, et al.
Publicado: (2012)

Frequencies of BCR-ABL1 fusion transcripts among Sudanese chronic myeloid leukaemia patients
por: Osman, Emad-Aldin I., et al.
Publicado: (2010)

Adenovirus detection in Guthrie cards from paediatric leukaemia cases and controls
por: Vasconcelos, G M, et al.
Publicado: (2008)

Mixed lineage leukaemia-4 regulates cell-cycle progression and cell viability and its depletion suppresses growth of xenografted tumour in vivo
por: Ansari, K I, et al.
Publicado: (2012)

Stat5 is indispensable for the maintenance of bcr/abl-positive leukaemia
por: Hoelbl, Andrea, et al.
Publicado: (2010)

Authenticity and drug resistance in a panel of acute lymphoblastic leukaemia cell lines
por: Beesley, A H, et al.
Publicado: (2006)

p53 and cell cycle independent dysregulation of autophagy in chronic lymphocytic leukaemia
por: Groves, M J, et al.
Publicado: (2013)

Microsatellite instability in patients with chronic B-cell lymphocytic leukaemia
por: Niv, E, et al.
Publicado: (2005)

STAT5 triggers BCR-ABL1 mutation by mediating ROS production in chronic myeloid leukaemia
por: Warsch, Wolfgang, et al.
Publicado: (2012)

Mutations in the BCR-ABL1 kinase domain in patients with chronic myeloid leukaemia treated with TKIs or at diagnosis
por: Liu, Jingjing, et al.
Publicado: (2020)

Cross-talk between Bcr-abl and the Thioredoxin System in Chronic Myeloid Leukaemia: Implications for CML Treatment
por: Clapper, Erin, et al.
Publicado: (2020)

Glucocorticoid resistance in T-lineage acute lymphoblastic leukaemia is associated with a proliferative metabolism
por: Beesley, A H, et al.
Publicado: (2009)

The role of TGF-β1–miR-21–ROS pathway in bystander responses induced by irradiated non-small-cell lung cancer cells
por: Jiang, Y, et al.
Publicado: (2014)

Expression pattern of tumour-associated antigens in hepatocellular carcinoma: association with immune infiltration and disease progression
por: Liang, J, et al.
Publicado: (2013)

Endoplasmic reticulum ribosome-binding protein 1, RRBP1, promotes progression of colorectal cancer and predicts an unfavourable prognosis
por: Pan, Y, et al.
Publicado: (2015)

Janus kinase 2 regulates Bcr–Abl signaling in chronic myeloid leukemia
por: Samanta, A, et al.
Publicado: (2011)

Cancer-associated fibroblasts induce epithelial–mesenchymal transition of breast cancer cells through paracrine TGF-β signalling
por: Yu, Y, et al.
Publicado: (2014)

Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of β-catenin in ovarian tumours
por: Wang, Y, et al.
Publicado: (2006)

Mutational analysis of oncogenic AKT E17K mutation in common solid cancers and acute leukaemias
por: Kim, M S, et al.
Publicado: (2008)

Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation
por: Rombout, Ans, et al.
Publicado: (2016)

Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia
por: McCarron, Sarah L., et al.
Publicado: (2013)

Pharmacogenetics of BCR/ABL Inhibitors in Chronic Myeloid Leukemia
por: Polillo, Marialuisa, et al.
Publicado: (2015)

MiR-125b acts as an oncogene in glioblastoma cells and inhibits cell apoptosis through p53 and p38MAPK-independent pathways
por: Wu, N, et al.
Publicado: (2013)

The transforming mutation E17K/AKT1 is not a major event in B-cell-derived lymphoid leukaemias
por: Mahmoud, I S, et al.
Publicado: (2008)

Proline-rich tyrosine kinase 2 and its phosphorylated form pY881 are novel prognostic markers for non-small-cell lung cancer progression and patients' overall survival
por: Kuang, B-H, et al.
Publicado: (2013)

Predictive value of miR-9 as a potential biomarker for nasopharyngeal carcinoma metastasis
por: Lu, J, et al.
Publicado: (2014)

Synthesis of the l- and d-SH2 domain of the leukaemia oncogene Bcr-Abl
por: Schmidt, Nina, et al.
Publicado: (2022)

Chronic lymphocytic leukaemia patients have a high risk of Merkel-cell polyomavirus DNA-positive Merkel-cell carcinoma
por: Koljonen, V, et al.
Publicado: (2009)

Serum microRNA panel as biomarkers for early diagnosis of colorectal adenocarcinoma
por: Zheng, G, et al.
Publicado: (2014)

Elevated expression of myosin X in tumours contributes to breast cancer aggressiveness and metastasis
por: Cao, R, et al.
Publicado: (2014)

Retraction Note: Disruption of the Bcr-Abl/Hsp90 protein complex: a possible mechanism to inhibit Bcr-Abl-positive human leukemic blasts by novobiocin
por: Wu, L. X., et al.
Publicado: (2020)

Leptin-mediated regulation of ICAM-1 is Rho/ROCK dependent and enhances gastric cancer cell migration
por: Dong, Z, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_u7d82k27qn9rsnq4a5pj5hgujr